Project Grant R01AG101704
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $683,924 Project Grant to Harvard Medical School (President and Fellows of Harvard College) on February 1, 2026, under the Aging Research program (CFDA 93.866) to conduct rigorous empirical research examining the effects of private equity acquisitions on U.S. hospice patient outcomes and healthcare utilization. The research will produce evidence-based findings on how private equity acquisition of hospices affects patient...
- This Project Grant award from the National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), aims to study the impact of hospice care on the well-being of Alzheimer's disease (AD) patients and their family members. The $318,416 project will leverage natural experiments from the opening of new hospice facilities to estimate the effects of hospice utilization on patient outcomes such as pain management, depression, and activities of daily living. It will...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a $452,375 Project Grant to The Trustees of Columbia University in the City of New York (Health Sciences Division) on May 1, 2026, under the Aging Research program (CFDA 93.866). The research project, titled "Impact of Nurse Practitioner Primary Care Models on Health Disparities Among Persons Living with Dementia," will be conducted through April 30, 2028, in New York, NY. The study will deliver novel...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded a Project Grant totaling $511,574 to The Trustees of Columbia University in the City of New York (Health Sciences Division) under the Aging Research program (CFDA 93.866), effective July 1, 2026, with completion targeted for April 30, 2031. This project develops statistical methods and computational approaches to identify heterogeneous treatment effects (HTEs) of interventions targeting modifiable Alzheimer's...
- Federal Project Grant Summary: EPIC-HHC Columbia University's Health Sciences Division received a $713,283 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded February 15, 2026, with completion targeted for January 31, 2030. The Enhancing Palliative Care Integration in Home Healthcare: Assessing Readiness, Identifying Needs, and Overcoming Challenges (EPIC-HHC) project develops evidence-based tools and assessment strategies to expand...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Johns Hopkins University a $3.16 million Project Grant under the Aging Research program (CFDA 93.866) effective July 1, 2026 through June 30, 2030. This research initiative, titled "Characterizing and Targeting Potentially Preventable Hospitalizations in Dementia," aims to reduce preventable hospital admissions among persons living with dementia (PLWD) by developing more accurate identification methods and...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $422,500 Project Grant to Icahn School of Medicine at Mount Sinai, effective September 1, 2025 through August 31, 2027, under the Aging Research program (CFDA 93.866). This research project investigates out-of-pocket spending (OOPS) and burdensome care experiences among older adults with serious illness. The research will examine how insurance generosity—a highly modifiable policy factor varying within insurance types...
- Federal Grant Award Summary Kaiser Foundation Hospitals, operating through its Kaiser Foundation Research Institute, received a $2.495 million Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) awarded September 15, 2025, with completion scheduled for June 30, 2030. This research initiative investigates missed home health care (HHC) in older adults with Alzheimer's disease and related dementias (ADRD) following hospital discharge. The project...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded the University of Rochester a $1.88 million Project Grant effective September 1, 2025, through May 31, 2030, under the Aging Research program (CFDA 93.866) to conduct rigorous quantitative analyses examining the effects of declining nursing home capacity on post-acute and long-term care access and health outcomes. Nursing homes serve as critical infrastructure in the U.S. post-acute and long-term care system,...
- Federal Grant Award Summary The National Institute on Aging awarded Columbia University's Health Sciences Division a $6.93 million Project Grant on August 1, 2025, under the Aging Research program (CFDA 93.866) to develop a multi-organ artificial intelligence-derived endophenotype (MAE) chart for personalized Alzheimer's disease and aging research. The four-year project, extending through July 31, 2029, will integrate large-scale multi-omics and multi-organ biomedical data with advanced...
Project Grant Award Summary The National Institute on Aging (NIA) awarded Columbia University's Health Sciences Division a Project Grant of $734,346 under the Aging Research program (CFDA 93.866) beginning August 1, 2026, and extending through April 30, 2030. This mixed-method, sequential explanatory research study, titled "Hospice Care After Increased Private-Equity Acquisition (HEAD-ON)," delivers comprehensive analysis examining the impact of private equity ownership on hospice care quality and end-of-life outcomes for patients with Alzheimer's disease and related disorders (ADRD). The project applies Donabedian's quality framework to quantify associations between private equity acquisition and hospice utilization patterns, quality metrics, and end-of-life outcomes; qualitatively examine care experiences and patient outcomes; and synthesize findings to develop evidence-based interpretations and recommendations for stakeholders. This research addresses a critical gap in understanding how the evolving hospice industry landscape—transitioning from nonprofit, volunteer-driven organizations to for-profit, private equity-dominated entities—influences care delivery and outcomes for the growing ADRD patient population. Deliverables include quantitative analyses using healthcare utilization and outcome datasets, qualitative findings from caregiver and provider interviews, and synthesized evidence-based recommendations to inform policy and practice regarding private equity ownership's implications for hospice quality and end-of-life care delivery.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $734.3k | 7/15/26 |